Jyong Biotech Ltd. (MENS)Healthcare | Biotechnology | New Taipei City, Taiwan | NasdaqGM
2.37 USD
+0.07
(3.043%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.33 -0.04 (-0.040%) ⇩ (Aug. 28, 2026, 4:23 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:02 a.m. EDT
This is a distressed biotech play with no safety net. The company is burning cash, sitting on negative book value, and carries significant debt against minimal liquidity. The price has collapsed from a high of $67 to under $2.20, reflecting a complete loss of market confidence in the current business model. While the CEO still holds a large stake, his recent losses highlight the severity of the situation. There is no dividend to provide income, and the balance sheet is fragile. The statistical forecast shows almost zero expected movement, and options data confirms a vacuum of interest. This is a speculative gamble on a turnaround that hasn't happened yet, not an investment opportunity. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.116546 |
| AutoARIMA | 0.116546 |
| MSTL | 0.120630 |
| AutoTheta | 0.192668 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.22 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.357 |
| Excess Kurtosis | -0.67 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 180,185,552 |
| Website | https://jyongbio.com |
As of Aug. 22, 2026, 4:02 a.m. EDT: Speculator positioning is extremely thin and fragmented. Call volume is negligible across most expirations, with a single small block of new buying at the $2.50 strike. Put activity is similarly sparse, concentrated at the $2.50 ATM level and a distant $7.50 strike. The lack of meaningful open interest or volume suggests no cohesive speculative thesis is currently forming; traders are essentially waiting for a catalyst rather than betting on a specific direction.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.96153843 |
| Address1 | No. 95, Xintai 5th Road |
| Address2 | 23F-3 Section 1 Xizhi District |
| All Time High | 67.0 |
| All Time Low | 1.43 |
| Ask | 2.56 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 28,110 |
| Average Daily Volume3 Month | 87,674 |
| Average Volume | 87,674 |
| Average Volume10Days | 28,110 |
| Bid | 1.51 |
| Bid Size | 2 |
| Book Value | -0.336 |
| City | New Taipei City |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.37 |
| Current Ratio | 0.446 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.42 |
| Day Low | 2.3 |
| Display Name | Jyong Biotech |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -2,507,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -77.107 |
| Enterprise Value | 193,307,184 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.1348 |
| Fifty Day Average Change | 0.23519993 |
| Fifty Day Average Change Percent | 0.110174224 |
| Fifty Two Week Change Percent | -96.15385 |
| Fifty Two Week High | 67.0 |
| Fifty Two Week High Change | -64.63 |
| Fifty Two Week High Change Percent | -0.96462685 |
| Fifty Two Week Low | 1.43 |
| Fifty Two Week Low Change | 0.93999994 |
| Fifty Two Week Low Change Percent | 0.6573426 |
| Fifty Two Week Range | 1.43 - 67.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,750,167,000,000 |
| Float Shares | 26,941,531 |
| Free Cashflow | 4,385,750 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 27 |
| Fullday Change | 0.0699999 |
| Fullday Change Percent | 3.04348 |
| Fullday Price | 2.33 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.622 |
| Held Percent Institutions | 0.00765 |
| Implied Shares Outstanding | 76,027,668 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-06-17 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. |
| Long Name | Jyong Biotech Ltd. |
| Market | us_market |
| Market Cap | 180,185,552 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1853012762 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -4,671,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 172,964,444 |
| Open | 2.3 |
| Operating Cashflow | -3,041,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 886 2 2732 5205 |
| Post Market Change | -0.03999996 |
| Post Market Change Percent | -1.6877621 |
| Post Market Price | 2.33 |
| Post Market Time | 1,787,948,591 |
| Previous Close | 2.3 |
| Price Hint | 4 |
| Price To Book | -7.053571 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.034 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0699999 |
| Regular Market Change Percent | 3.04348 |
| Regular Market Day High | 2.42 |
| Regular Market Day Low | 2.3 |
| Regular Market Day Range | 2.3 - 2.42 |
| Regular Market Open | 2.3 |
| Regular Market Previous Close | 2.3 |
| Regular Market Price | 2.37 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 22,344 |
| Return On Assets | -0.12005 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 74,233,667 |
| Shares Percent Shares Out | 0.0023999999 |
| Shares Short | 177,218 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 240,724 |
| Short Name | Jyong Biotech Ltd. |
| Short Percent Of Float | 0.0043 |
| Short Ratio | 3.59 |
| Source Interval | 15 |
| Symbol | MENS |
| Total Cash | 1,175,000 |
| Total Cash Per Share | 0.016 |
| Total Debt | 18,549,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.97965 |
| Two Hundred Day Average Change | -3.6096501 |
| Two Hundred Day Average Change Percent | -0.60365576 |
| Type Disp | Equity |
| Volume | 22,344 |
| Website | https://jyongbio.com |
| Zip | 221 |